Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-MAPRE2 (1-327) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:1000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
MAPRE2 |
Gene ID: |
10982 |
Uniprot ID: |
MARE2_HUMAN |
Immunogen Region: |
1-327 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-327 of human MAPRE2 (NP_001137298.1). |
Immunogen Sequence: |
MAVNVYSTSITQETMSRHDI IAWVNDIVSLNYTKVEQLCS GAAYCQFMDMLFPGCISLKK VKFQAKLEHEYIHNFKLLQA SFKRMNVDKVIPVEKLVKGR FQDNLDFIQWFKKFYDANYD GKEYDPVEARQGQDAIPPPD PGEQIFNLPKKSHHANSPTA GAAKSSPAAKPGSTPSRPSS AKRASSSGSASKSDKDLETQ VIQLNEQVHSLKLALEGVEK ERDFYFGKLREIELLCQEH |
Tissue Specificity | Expressed in different tumor cell lines. Up-regulated in activated B- and T-lymphocytes. |
Function | May be involved in microtubule polymerization, and spindle function by stabilizing microtubules and anchoring them at centrosomes. May play a role in cell migration. |
Protein Name | Microtubule-Associated Protein Rp/Eb Family Member 2Apc-Binding Protein Eb2End-Binding Protein 2Eb2 |
Cellular Localisation | CytoplasmCytoskeletonAssociated With The Microtubule NetworkAccumulates At The Plus End Of Microtubules |
Alternative Antibody Names | Anti-Microtubule-Associated Protein Rp/Eb Family Member 2 antibodyAnti-Apc-Binding Protein Eb2 antibodyAnti-End-Binding Protein 2 antibodyAnti-Eb2 antibodyAnti-MAPRE2 antibodyAnti-RP1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance